Upcoming event

Tags

Abiraterone, Active surveillance, Adjuvant, ADT, Advanced prostate cancer, Alkaline phosphatase, Alternative splicing, Androgen, Androgen deprivation therapy, Androgen pathway blockade, Androgen receptor inhibitor, Antiandrogens, Anticancer agents, ARCHES, Article of the Month, artificial intelligence, ASCO GU21, ASCO GU22, ASCO21, AUA21, BHC80, Biochemical recurrence, Biomarkers, Biopsy, Bisphosphonates, Bone metastases, BRCA1, BRCA2, Castrate-resistanter, Castration-resistant, Chemotherapy, Clinical trial, Clinical trials, Cohort study, COVID-19, cSP, Deferred treatment, Diagnosis, Disease progression, Docetaxel, EAU21, EAU22, Emission-computed, EMUC21, EMUC22, End-to-side nerve grafting, Enzalutamide, Erectile dysfunction, Erectile function, ESMO21, ESMO22, ESOU Online, ESU Masterclass, ESU Masterclasses, External beam radiotherapy, Focal therapy, Frozen section, Fusion biopsies, Genomic classifier, Genomics, Guidelines, hormone-sensitive, HORRAD, HRQL, Image guided biopsy, Imaging, Immunohistochemistry, Index lesion, Indocyanine green, Intensity-modulated radiotherapy, Local radiotherapy, Localised, Localized, Localized prostate cancer, Lymph node excision, Lymphadenectomy, Mapping, Mass spectrometry, Masterclass, Masterclasses, MDV3100, Membranous urethra, Meta-analysis, Metastasis, Metastasized, Metastatic, Mortality reduction, mp-MRI, MRI, Neoplasm staging, Nerve sparing, Next-generation sequencing, Nomogram, Noncastrate, Orchiectomy, Overdiagnosis, p53, Patient information, PCa21, Penile rehabilitation, PET/CT, Positron emission tomography, Precision medicine, Pretreatment risk stratification, Pretreatment tables, Primary tumor treatment, Prognosis, Prognostic model, Prostasomes, Prostate screening, Prostate-specific antigen, Prostate-specific membrane antigen, Prostatic neoplasms, ProtecT trial, Proteomics, PSA, PSA flare, PSA kinetics, PSA screening, PSMA PET/CT, PTEN, Quality of life, Radiation therapy, Radical prostatectomy, Randomized prospective trial, Randomized trial, Randomized trials, Rapid metastasis, Rb, RB1, Receptors, Risk stratification, RNA splicing, Robotic prostatectomy, Robotic surgery, Robotic Urology, Robotics, Salvage therapy, Screening, Sentinel lymph node, Sexual quality of life, SREs, SRRM4, STAMPEDE, Stereotactic body radiotherapy, Surgical margins, Surgical video, Surgical videos, Systematic biopsy, Systematic review, Targeted Biopsy, TITAN, TP53, Transcriptome, Transperineal template biopsy, Tumor suppressor genes, Ultrasensitive PSA, Urinary incontinence, Urological surgery, UROonco25, Urowebinar, WCRF/AICR CUP, Webinar, Wnt, Zoledronic acid
Show all

A Specific Mapping Study Using Fluorescence Sentinel Lymph Node Detection in Patients with Intermediate- and High-risk Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection

European Urology, Volume 70, Issue 5, November 2016, Pages 734-737

Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer

J Urol., Volume 193, Issue 3, March 2015, Pages 807-811

Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis

J Urol. 2015 Feb;(2):-6., Volume 193, Issue 2, February 2015, Pages 552-553

Active surveillance for localized prostate cancer: an analysis of patient contacts and utilization of healthcare resources

Scand J Urol., Volume 49, Issue 1, February 2015, Pages 43-50

Systematic review and meta-analysis of factors determining change to radical treatment in active surveillance for localized prostate cancer

Eur Urol., Volume 67, Issue 6, June 2015, Pages 993-1005

Anxiety in the management of localised prostate cancer by active surveillance

114 Suppl 1:55-61

Why and Where do We Miss Significant Prostate Cancer with Multi-parametric Magnetic Resonance Imaging followed by Magnetic Resonance-guided and Transrectal Ultrasound-guided Biopsy in Biopsy-naïve Men?

European Urology, Volume 71, Issue 6, June 2017, Pages 896-903

MRI-targeted or standard biopsy for prostate-cancer diagnosis

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

N Engl J Med 2017 Jul 27

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

N Engl J Med. 2017 Jun 04

Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery

Oncotarget. 2017 Mar 14, Volume 8, Issue 11, Pages 18497-18512

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

The Lancet 2017 Feb 25, Volume 389, Issue 10071, Pages 815-822

PreviousNext